AzTrials
AzTrials

Hypotension During SurgeryNCT06247384

The Hypotension Prediction Index in Major Abdominal Surgery

A study testing Hypotension Prediction Index Hemodynamic Monitoring in people with Hypotension During Surgery, run by Jakub Szrama at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized clinical trial is to compare different types of advanced hemodynamic monitoring in patients undergoing major abdominal surgery. Participants undergoing major abdominal surgery will receive anesthesia with two different types of hemodynamic monitoring - group A will receive arterial pressure… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Hypotension During Surgery
What is being tested?
Hypotension Prediction Index Hemodynamic Monitoring
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
226 participants
Where
1 sitePoland
Study dates
1 Jan 2025to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients qualified for elective major abdominal surgery, defined as an expected duration of more than two hours, an estimated blood loss of >15% of blood volume, or an expected transfusion requirement of at least two packed red blood cells with general or combined anaesthesia.
  • Patients with American Society of Anesthesiologists (ASA) status III or IV.
  • Written informed consent.

Who cannot join

  • Patients under 18 years
  • Lack of health insurance
  • Pregnancy
  • Known history of congenital heart disease, severe aortic and/or mitral stenosis, heart failure and ejection fraction < 35 %
  • Persistent atrial fibrillation and other arrhythmias impairing arterial pressure cardiac output monitoring

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jakub Szrama, Ph.D. contact

+48602170037

jakub.szrama@usk.poznan.pl

Agata Gradys, Ph.D. contact

+48618691856

agata.gradys@usk.poznan.pl

Poland1 site, 1 recruiting
  • Department of Anesthesiology, Intensive Therapy and Pain Management

    Poznan, Poznań, 60-355

    Jakub Szrama, PhD, +48618691856, jakub.szrama@gmail.com

    Agata Gradys, PhD, +48618691856, agatagradys@gmail.com

    Recruiting

Other trials in Poland

About this study

Official title: The Hypotension Prediction Index in Major Abdominal Surgery - a Prospective Randomized Clinical Trial.

The goal of this randomized clinical trial is to compare different types of advanced hemodynamic monitoring in patients undergoing major abdominal surgery.

Participants undergoing major abdominal surgery will receive anesthesia with two different types of hemodynamic monitoring - group A will receive arterial pressure cardiac output algorithm with the FloTrac sensor and group B will receive hemodynamic monitoring with the Hypotension Prediction Index.

The main question the study aims to answer is:

  • will the hypotension prediction index algorithm reduce the rate of hypotension in comparison to arterial pressure cardiac output algorithm.
Read the detailed description

The fundamental aspect of the anesthetics perioperative management is to maintain hemodynamic stability, with special attention on the avoidance or reduction of the episodes of intraoperative hypotension (IOH). The incidence of intraoperative hypotension is related to an increased rate of perioperative morbidity and mortality. Even a short period of hypotension can be related to an increased risk of postoperative stroke, myocardial injury and acute kidney injury. Patients undergoing major abdominal surgery are at a high-risk of IOH because such surgeries typically require more than 2h to complete and require blood transfusion or inotrope administration. Hemodynamic monitoring and the use of goal directed therapy protocols helps to diminish the incidence of perioperative complications, however the hypotension management remains a reactive approach, an intervention is made when the hypotension has already occured. The Hypotension Prediction Index is an machine learning algorithm which allows to predict the episodes of hypotension and intervene before mean arterial pressure drops below 65 mmHg. The aim of the current study is to compare the rate of hypotension in patients undergoing major abdominal surgery with the arterial pressure cardiac output algorithm and the hypotension prediction index algorithm.

Being tested
Hypotension Prediction Index Hemodynamic Monitoring
Keywords
hypotension prediction index, major abdominal surgery, arterial pressure cardiac output, intraoperative hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypotension Prediction Index Hemodynamic MonitoringDevice

    The application of the perioperative hemodynamic management according to the hypotension prediction index algorithm.

Study groups in NCT06247384
Study groupRoleWhat they receive
Group A - FloTrac groupNo interventionPatients receiving standard therapy with the arterial pressure cardiac output hemodynamic monitoring
Group B - HPI - Hypotension Prediction Index groupExperimentalPatients receiving therapy according to the hypotension prediction index hemodynamic monitoring.
Receives: Device: Hypotension Prediction Index Hemodynamic Monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time weighed average of hypotension below 65 mmHg

    depth of hypotension in millimetres of mercury below a mean arterial pressure (MAP) of 65 mmHg x time in minutes spent below MAP of 65mmHg)/total duration of operation in minutes

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

Secondary outcomes (10)
  1. Time weighed average of hypotension below 50 mmHg

    depth of hypotension in millimetres of mercury below a MAP of 50 mmHg x time in minutes spent below MAP of 50 mmHg)/total duration of operation in minutes

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

  2. Time weighed average of hypertension above 90 mmHg

    rise of hypertension in millimetres of mercury above a MAP of 90 mmHg x time in minutes spent above MAP of 90 mmHg)/total duration of operation in minutes

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

  3. Time weighed average of hypertension above 100 mmHg

    rise of hypertension in millimetres of mercury above MAP of 100 mmHg x time in minutes spent above MAP of 100 mmHg)/total duration of operation in minutes

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

  4. 30 day mortality

    30 day mortality

    Measured: 30 consecutive days starting from the day of the surgery

  5. Length of hospitalisation

    Length of hospitalisation

    Measured: From the date of randomisation to the date of hospital discharge or death, whichever comes first, assessed up to 30 days

  6. Myocardial injury evaluated by postoperative troponin levels

    Myocardial injury evaluated by postoperative troponin levels

    Measured: First, second and fifth postoperative day

  7. Kidney injury evaluated by creatinine levels

    Kidney injury evaluated by creatinine levels (increase in sCr by ≥0.3 mg/dL within 48 hours; increase in sCr to 1.5 times baseline; or urine volume less than 0.5 mL/kg/h for 6 hours)

    Measured: First, second and fifth postoperative day

  8. Intraoperative fluid dose

    Intraoperative fluid administration

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

  9. Intraoperative vasopressor dose

    Intraoperative vasopressor dose

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

  10. Rate of intra and postoperative atrial fibrillation

    the occurrence of atrial fibrillation in the intraoperative and postoperative period up to 30 days

    Measured: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2024
  2. Study start1 Jan 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
226 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06247384
Sponsor's protocol ID
PoznanUMSHPI
Status last verified
Jul 2025
First submitted
9 Jan 2024
Last updated
3 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Szrama J, Gradys A, Nowak Z, Lohani A, Zwolinski K, Bartkowiak T, Wozniak A, Koszel T, Kusza K. The hypotension prediction index in major abdominal surgery - A prospective randomised clinical trial protocol. Contemp Clin Trials Commun. 2024 Dec 28;43:101417. doi: 10.1016/j.conctc.2024.101417. eCollection 2025 Feb.

    PubMed 39895857

Questions about this trial

What is this clinical trial studying?

A study testing Hypotension Prediction Index Hemodynamic Monitoring in people with Hypotension During Surgery, run by Jakub Szrama at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jakub Szrama, Ph.D. (+48602170037, jakub.szrama@usk.poznan.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time weighed average of hypotension below 65 mmHg (time frame: "From the beginning of the anesthesia to the end of anesthesia (from induction - start of anesthesia to end of anesthesia - discharge from the post anesthesia department), assessed up to 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06247384, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in